Dexcom | DXCM - Spese Operative

Prezzo Delle Azioni
60.77
Cambio Giornaliero
1.25 2.10%
Mensile
-3.23%
Annuale
-13.51%
Q2 Previsione
60.25




Spese Operative Cambiamento Data
Abbott USD 9.31B 104M 2026-03
Align Technology USD 862.03M 39.18M 2026-03
AtriCure USD 138.01M 3.95M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.15B 107M 2026-03
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 645.11M 241.46M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
J&J USD 17.44B 1.53B 2026-03
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 337.72M 2.02M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Solventum Corp USD 1.89B 3.09B 2025-12
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
West Pharmaceutical Services USD 2.99B 2.35B 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03